Conavi Medical Corp.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
28.4M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Healthcare
Medical Devices
TSXV
Key Financial Metrics
9.1M
Revenue
-20.5M
Net Income
C$-0.36
EPS (Diluted)
-25.3M
Free Cash Flow
Profitability
Gross Margin
83.6%
Operating Margin
-162.8%
Net Profit Margin
-224.9%
EBITDA
-8.0M
Returns & Efficiency
Return on Assets (ROA)
-164.9%
Return on Equity (ROE)
-
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
12.4M
Total Debt
19.9M
Debt to Equity
-
Current Ratio
1.01
Company Info
| Industry | Medical Devices |
| HQ | Toronto, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | www.conavi.com/novasight/ |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
43,500,360
Shares Sold
0
Total Transactions
3
SEDAR+ Filings
View All Filings2
Annual Reports
14
Quarterly Reports
16
MD&A
117
News Releases
14
Material Changes
8
Prospectuses
6
Governance
36
Certifications
87
Other
●
2026-02-26
●
2025-12-29
Interactive Charts
Company Profile
General Information
| Company Name | Conavi Medical Corp. |
| Ticker | CNVI.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Medical Devices |
| Headquarters | Toronto, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | www.conavi.com/novasight/ |
Financial Summary
| Market Cap | 28.4M |
| Revenue | 9.1M |
| Net Income | -20.5M |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.36 |
| Net Margin | -224.9% |
| ROE | N/A |
| Dividend Yield | N/A |
Business Description
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.